{
 "company": {
  "id": "abbvie",
  "name": "AbbVie Inc.",
  "country": "US",
  "template": "corporate",
  "cik": "0001551152",
  "tickers": [
   "ABBV"
  ],
  "sources": "10-K and 10-Q filings with the SEC, published by SEC EDGAR"
 },
 "snapshot": "FY2026Q2_c0beb545",
 "schema": "annalist.dataset/0.1",
 "dataset_sha256": "c0beb545007b6e6246534288c911f21dcf60f8eef2c74e3b2ee1914c705d8ce3",
 "as_of": {
  "period": "FY2026 Q2",
  "period_end": "2026-06-30",
  "release_date": "2026-08-03"
 },
 "published_at": "2026-10-22T13:14:33+00:00",
 "coverage": {
  "first_fiscal_year": 2020,
  "latest_period": "FY2026 Q2",
  "rule": "fiscal years ending on or after 2020-12-31"
 },
 "conventions": {
  "amounts": "US dollars as reported, not scaled; per-share items in US dollars per share; share counts in shares; pure items as fractions",
  "signs": "revenue, expenses, taxes and payments are positive amounts; operating, investing and financing cash-flow totals are negative when cash flows out",
  "fiscal_year": "the company's own fiscal-year label; start and end dates are given for every period",
  "period_label": "FY<year> Q<n>",
  "quarters": "a quarter that the filings do not report on its own, such as a fourth quarter, is derived from the figures of the filings",
  "restatements": "each value comes from the latest filing that reports the period; earlier different values are listed in restatements",
  "comparison": "a change against the same period a year earlier compares 2 figures of one basis, as the latest report that presents both periods gives them, so that a restatement or a stock split between 2 reports does not count as a change; where these figures differ from the published ones, the row of the later period gives them under comparison, with their sources and the fiscal year of the report (basis), and a comparison of null means that no report presents both",
  "definitions": "each item keeps one definition across periods",
  "withheld": "a value that contradicts the definition of its item, or that the filings report in contradiction, is withheld: it is empty and listed in withheld with its reason and sources",
  "source_ids": "<form>:<accession number>; see documents",
  "events": "corporate events found in the filings since 2020, such as acquisitions, disposals, stock splits, restatements and changes of name; each names its type and its source documents",
  "notes": "items with group note come from the notes to the financial statements; a note item that a filing does not report is empty, which differs from a reported zero; pure items are fractions, so 0.045 means 4.5%",
  "debt": "total debt counts each borrowing once; a balance-sheet date at which the company has no debt carries nil debt",
  "methods": "method is reported, or derived where the figure is calculated from figures of the documents listed",
  "published_at": "the time, in UTC, at which Annalist wrote the snapshot to the site for the first time; the snapshot of a company that a reader could cite on a date is the latest whose published_at is not after that date"
 },
 "validation": {
  "total": 294,
  "failed": 0,
  "warnings": 9
 },
 "adjustments": [],
 "restatements": 12,
 "guidance": null,
 "statements": [
  {
   "statement": "income_statement",
   "frequency": "quarterly",
   "section": "pl_quarterly",
   "url": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/statements/pl_quarterly.json",
   "rows": 26,
   "first": "FY2020 Q1",
   "last": "FY2026 Q2",
   "items": [
    "cost_of_revenue",
    "dps_declared",
    "eps_basic",
    "eps_diluted",
    "gross_profit",
    "income_tax",
    "interest_expense",
    "net_income",
    "net_income_common",
    "net_income_incl_nci",
    "operating_income",
    "operating_lease_cost",
    "pretax_income",
    "revenue",
    "rnd",
    "sga",
    "shares_basic",
    "shares_diluted"
   ]
  },
  {
   "statement": "income_statement",
   "frequency": "annual",
   "section": "pl_annual",
   "url": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/statements/pl_annual.json",
   "rows": 6,
   "first": "FY2020",
   "last": "FY2025",
   "items": [
    "cost_of_revenue",
    "dps_declared",
    "eps_basic",
    "eps_diluted",
    "gross_profit",
    "income_tax",
    "interest_expense",
    "net_income",
    "net_income_common",
    "net_income_incl_nci",
    "operating_income",
    "operating_lease_cost",
    "pretax_income",
    "revenue",
    "rnd",
    "sga",
    "shares_basic",
    "shares_diluted"
   ]
  },
  {
   "statement": "balance_sheet",
   "frequency": "quarter_end",
   "section": "balance_sheet",
   "url": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/statements/balance_sheet.json",
   "rows": 26,
   "first": "FY2020 Q1",
   "last": "FY2026 Q2",
   "items": [
    "accounts_payable",
    "accrued_taxes_current",
    "cash",
    "commercial_paper",
    "current_assets",
    "current_liabilities",
    "debt_current",
    "debt_maturity_after_y5",
    "debt_maturity_y1",
    "debt_maturity_y2",
    "debt_maturity_y3",
    "debt_maturity_y4",
    "debt_maturity_y5",
    "equity_method_investments",
    "equity_parent",
    "equity_total",
    "goodwill",
    "intangibles",
    "inventory",
    "liabilities_and_equity",
    "long_term_debt",
    "long_term_investments",
    "nci",
    "operating_lease_discount_rate",
    "operating_lease_imputed_interest",
    "operating_lease_liability",
    "operating_lease_liability_current",
    "operating_lease_liability_noncurrent",
    "operating_lease_payments_total",
    "operating_lease_payments_y1",
    "ppe_net",
    "preferred_stock",
    "receivables",
    "retained_earnings",
    "shares_outstanding",
    "short_term_borrowings",
    "short_term_investments",
    "temporary_equity",
    "total_assets",
    "total_liabilities"
   ]
  },
  {
   "statement": "cash_flow",
   "frequency": "quarterly",
   "section": "cf_quarterly",
   "url": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/statements/cf_quarterly.json",
   "rows": 26,
   "first": "FY2020 Q1",
   "last": "FY2026 Q2",
   "items": [
    "amortisation_intangibles",
    "buybacks",
    "capex",
    "cff",
    "cfi",
    "cfo",
    "change_contract_liabilities",
    "change_inventories",
    "change_payables",
    "change_receivables",
    "d_and_a",
    "deferred_tax",
    "depreciation",
    "dividends_paid",
    "goodwill_impairment",
    "interest_paid",
    "proceeds_debt_issuance",
    "proceeds_equity_issuance",
    "sbc",
    "taxes_paid"
   ]
  },
  {
   "statement": "cash_flow",
   "frequency": "annual",
   "section": "cf_annual",
   "url": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/statements/cf_annual.json",
   "rows": 6,
   "first": "FY2020",
   "last": "FY2025",
   "items": [
    "amortisation_intangibles",
    "buybacks",
    "capex",
    "cff",
    "cfi",
    "cfo",
    "change_contract_liabilities",
    "change_inventories",
    "change_payables",
    "change_receivables",
    "d_and_a",
    "deferred_tax",
    "depreciation",
    "dividends_paid",
    "goodwill_impairment",
    "interest_paid",
    "proceeds_debt_issuance",
    "proceeds_equity_issuance",
    "sbc",
    "taxes_paid"
   ]
  }
 ],
 "ratios": {
  "url": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/ratios/index.json",
  "template": "corporate",
  "ratios": 68,
  "values": 2025,
  "frequencies": [
   "annual",
   "quarterly",
   "ttm"
  ],
  "engine": "annalist 0.1.0 (ratios 0.6.0)"
 },
 "documents": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/documents.json",
 "files": [
  {
   "path": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/balance_sheet.csv",
   "bytes": 122311,
   "sha256": "1f38d888556199758da3c7e6c590c00a9353ce7ac86fdc4967fcf419d45ef6fa"
  },
  {
   "path": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/cf_annual.csv",
   "bytes": 15962,
   "sha256": "a97b13b2a07612af66828281e61186dca1041b92346281986115328434762019"
  },
  {
   "path": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/cf_quarterly.csv",
   "bytes": 77004,
   "sha256": "7f27dcc129616e45aa5b8894ed196f7ff9399a557ab992ffde4af84a2bf27a80"
  },
  {
   "path": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/dataset.json",
   "bytes": 251237,
   "sha256": "cc89d51178098674773d7cfbadb9dfce5e495fdf2ef402fd1ce484df44f8cc49"
  },
  {
   "path": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/documents.csv",
   "bytes": 6663,
   "sha256": "01490cf653fdf876b0f33abc55bcc9382702123f1c3e14af37d78ac3b8a1e49d"
  },
  {
   "path": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/documents.json",
   "bytes": 10693,
   "sha256": "40a8a94b08efa3000435c6761660623f1da6622fdb7f9eb3dee2a98a32fb4e34"
  },
  {
   "path": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/pl_annual.csv",
   "bytes": 14502,
   "sha256": "832ffe9edddb994cff4055eddcfa6aceb2febd8808086a4d0ab43cb7ad2572ae"
  },
  {
   "path": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/pl_quarterly.csv",
   "bytes": 63235,
   "sha256": "0eb1b18165966b3474811cf25cba5daa28a00b8cb3a8fd9b45c09d366597da3d"
  },
  {
   "path": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/ratios/annual.json",
   "bytes": 240554,
   "sha256": "5ca0b1531a5cece2dcc4c70526b2a80911ebb8d635afb044268e9ae7ed201101"
  },
  {
   "path": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/ratios/index.json",
   "bytes": 40180,
   "sha256": "7a4033ca3f1545fb33f621e4320fbbf7aac206d25498c664f7ed941d282678b9"
  },
  {
   "path": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/ratios/quarterly.json",
   "bytes": 265896,
   "sha256": "852b87aa83309c3069b532f157e54d8019d08a1d974b577f9e6ebcbcce3a292e"
  },
  {
   "path": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/ratios/ttm.json",
   "bytes": 1015177,
   "sha256": "4e64f4ce9d94c98b69e4e2cd930aa10ab3510bdab6ad737fef20e9dc9562f2ab"
  },
  {
   "path": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/ratios.csv",
   "bytes": 875592,
   "sha256": "9c23e9c0993395d16174d9b97d13b798d1f48d33b930a4d68206b3cbdd0d4b83"
  },
  {
   "path": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/ratios.json",
   "bytes": 1386399,
   "sha256": "3fd990a61033e59fea98c1f7c33cf2e99fed56c5a2f29fc6bc8b3e6b8409972d"
  },
  {
   "path": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/restatements.csv",
   "bytes": 1918,
   "sha256": "7ab7dfb853a4fe3605dc231fa492b8ed316ff291a6c5458589e5f8e039274995"
  },
  {
   "path": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/statements/balance_sheet.json",
   "bytes": 89253,
   "sha256": "a178dfa992c286fb964f0aba0ed44459dd5b99a699ba1e315f81d80c96e22ef9"
  },
  {
   "path": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/statements/cf_annual.json",
   "bytes": 16889,
   "sha256": "1017bde20c0e436c60c2f2134380aac258473a60c2d7dc8cda556b4e7289929f"
  },
  {
   "path": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/statements/cf_quarterly.json",
   "bytes": 69917,
   "sha256": "fdbb93e6a2a4a847a73f718f0604d74de53c5c9bd67f650bab7bc837f030c55b"
  },
  {
   "path": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/statements/pl_annual.json",
   "bytes": 16378,
   "sha256": "231455eb59a132e4da19149042f9dda3a82b969b4c406e100f7156799badf844"
  },
  {
   "path": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/statements/pl_quarterly.json",
   "bytes": 55668,
   "sha256": "d3d7dfb0c88fd9c384ec6e165aa9b26e82462c4137aba8667831b52dd8901251"
  },
  {
   "path": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/tables.json",
   "bytes": 10532,
   "sha256": "5ff3c0ca50b36d048a069a273ee39296ee634a364dc7689c4ccb8a62726a4153"
  },
  {
   "path": "/api/v1/companies/abbvie/snapshots/FY2026Q2_c0beb545/validation.json",
   "bytes": 3819,
   "sha256": "f97b6bd65ac77bd6e5ebba843feff369266019b8ddb3ed37d480c9a051cdc2ec"
  }
 ],
 "citation": {
  "format": "Annalist, {company name}, snapshot {company id}/{snapshot id} (as of {period}); {item label}, {period}; source {document id} ({document url})",
  "example": "Annalist, AbbVie Inc., snapshot abbvie/FY2026Q2_c0beb545 (as of FY2026 Q2); <item label>, <period>; source <document id> (<document url>)",
  "note": "Document ids name the official document of each figure; documents.json gives its URL and SHA-256."
 }
}